25. Osborne CK, Coronado EB, Arteaga CL . Kitten LJ, Fuqua SAW, Ramashanna K, Marshall M, Li CH. Insulin-like 
growth factor II (IGF-H): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I 
receptor. Mol Endocrinol. 3:1701-1709,1989. 
26. Arteaga CL . Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM. Growth stimulation of human breast 
cancer cells with anfi-TGF/3 antibodies: Evidence for negative autocrine regulation by TGF/S. Cell Growth & 
Differentiation. 1:367-374, 1990. 
2. . Osborne CK, Clemmons DR, Arteaga CL . Regulation of breast cancer growth by insulin-like growth factors. J Steroid 
Biochem 37:805-809, 1990. 
28. Arteaga CL . Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL. Elevated content of the tyrosine kinase 
substrate phospholipase C-7I in p rimar y h uman breast carcinomas. Proc Nad Acad Sci USA, 88:10435-10439, 1991. 
29. Arteaga CL . Coffey RJ. Transfo rming growth factor-fl isoforms in mammary neoplasia: More-questions than answers. 
Human Pathol 23:1-3, 1992. 
30. Arteaga CL . Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res Treat 
22:101-106, 1992. 
31. Romano M, Polk W, Awad J, Arteaga CL . McClure RW, Nanney LB, Coffey RJ. Transfo rming growth factor a 
protection against drug-induced injury to the rat gastric mucosa. J Clin Invest 90:2409-2421, 1992. 
32. Arteaga CL . Carty-Dugger T, Moses HL, Hurd SD, Pietenpol JA Transforming growth factor (TGF) -131 can induce 
estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth & differentiation 4: 193- 
201, 1993. 
33. Halter S, Winnier AR, Arteaga CL . Pretreatment with vi tamin A inhibits transforming growth factor a stimulation of 
human mammary car cinoma cells. J Cell Physiol 156:80-87, 1993. 
34. Hemandez-Sotomayor SMT, Arteaga CL . Soler C, Carpenter G. Epidermal growth factor stimulates substrate selective 
phosphotyrosine phosphatase activity. Proc Nad Acad Sci USA 90:7691-7695, 1993. 
35. Johnson MD, Ho rib a M, Winnier AR, Arteaga CL . The epidermal growth factor receptor tyrosine kinase is associated 
with phospholipase C-yl in me ningi o mas . H uman Pathol 25:146-153, 1994. 
36. Shawver LK, Mann E, Ellinger SS, Carty-Dugger T, Arteaga CL . Ligand-like effects induced by anti-c-erbB-2 antibodies 
do not correlate and are not required for growth inhib ition of h uman carcinoma cells. Cancer Res 54: 1367-1373, 1994. 
37. Arteaga CL . Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT. Anti-transforming growth factor (TGF)-B 
antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: Implications for 
a possible role of tumor cell/host TGFfl interactions in human breast cancer progression, J Clin Invest 92:2569-2576, 
1993. 
3*- Arteaga CL . Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ. pl85 6 ' <,<>B ' 2 signaling 
enhances cisplatin-indnced cytotoxicity in h uman breast carcinoma cells: Association between an oncogenic receptor 
tyrosine kinase and drug-induced DNA repair. Cancer Res (In press), 1994. 
39. Arteaga CL . Dugger TC, W inni er AR, Elsea SH, Osheroff N. Activation of pl85 c " etbB ' 2 phosphorylates topoisomerase 
II and enhances etopo side-induced cytotoxicity in h uman breast carcinoma cells. Submitted. 
40. Disatnik M-H, Winnier AR Mochly-Rosen D, Arteaga CL . Distinct responses of protein kinase C isozymes to c-erbB-2 
activation in SKBR-3 human breast carcinoma cells. Cell Growth & Diff (In press), 1994. 
41. Arteaga CL . Dugger TC, W inni er AR, Forbes JT. Evidence for a positive role of transforming growth factor B inhuman 
breast cancer cell tumorigenesis. J Cell Biochem 17G: 187-193, 1993. 
42. Moses HL, Arteaga CL . Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R. Proc 22nd Int Symp The 
Princess Takamatsu Cancer Res Fund, Tokyo, 1993: Transfo rming growth factor B regulation of cell proliferation. In; 
Multistage Carcinogenesis, CC Harris, S Hirohashi, N Ito, et al (eds), Japan Scientific Societies Press, Tokyo, 1994. 
43. Arteaga CL . Hurd SD, Dugger TC, Winnier AR, Robertson JB. Epidermal growth factor (EGF) receptors in hu m a n 
breast carcinoma cells: A pote ntial selective target for transfo rming growth factor a-Pseudomonas exotoxin 40 (TGFa- 
PE40) fusion protein. Cancer Res (In press), 1994. 
44. Arteaga CL . Epidermal growth factor receptors and erbB-2 in human lung cancer. In: Lung Cancer Principles and 
Practice. Pass HI, Mitchell J, Johnson DH, and Turrisi AT (eds), J.B. Lippincott Company, Philadelphia, PA, 1994. 
[190] 
Recombinant DNA Research, Volume 20 
